You must log in to view this page.

Milestone Pharmaceuticals Inc. – Filings and Transcripts

NASDAQ: MIST
Share price (7/6/26): $1.32
Market cap (7/6/26): $164 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Shelf registration

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Ownership Filter

Wills Robert James

Fischer Seth H. Z.

Tomsicek Michael John

News Filter

Change in Directors, Officers or Compensation, Shareholder Vote Results, Financial Statements or Exhibits

Announces First Quarter 2026 Financial Results and Provides Corporate Update

Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Update on the Commercial Launch of CARDAMYST™ (Etripamil) Nasal Spray for the Treatment of PSVT

Announces U.S. Availability of CARDAMYST™ (Etripamil) Nasal Spray, the First and Only FDA-Approved Self-Administered Treatment for Adults With Paroxysmal Supraventricular Tachycardia

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC